Sai Parenterals Limited (SAIPARENT) — Announcement
Sai Parenterals Limited announced compliance with SEBI Depositories and Participants Regulations 2018 for the quarter ended June 30, 2026, confirming dematerialization details were submitted to BSE and NSE via RTA confirmation dated July 10, 2026.
About Sai Parenterals Limited (SAIPARENT)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when SAIPARENT files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SAIPARENT — Free💡 Ask AI about this filing
📊 More SAIPARENT filings
- 🟡 Board Meeting — 6 July 2026 Sai Parenterals Limited announced the outcomes of its board meeting held on July 6, 2026, appointing...
- Announcement — 1 July 2026 Sai Parenterals announced that its Australian subsidiary Noumed Pharmaceuticals renewed an exclusive...
- Announcement — 1 July 2026 Sai Parenterals announced its subsidiary Noumed Pharmaceuticals secured an exclusive OTC medicine su...
- Financial Results — 29 June 2026 Sai Parenterals Limited announced that its trading window will close on 01.07.2026 for all designate...
- Announcement — 28 May 2026 Sai Parenterals Limited announced it received a USD 11 million purchase order at Rs.95 per share (Rs...
🔥 Also filed on 18 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when SAIPARENT files new disclosures
Track SAIPARENT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SAIPARENT — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research